Celebrating Changemakers: TAG's 2025 Research in Action Awards

TAG to Honor Distinguished Leaders at the 2025 Ceremony
New York, the highly anticipated Research in Action Awards by TAG is coming soon. This yearly event draws together supporters and community members to celebrate outstanding contributions to the fight against HIV, TB, and HCV. The occasion is set to take place at the prestigious Angel Orensanz Foundation, promising a night of memorable experiences in the spirit of activism.
Recognizing Exceptional Achievements
This year's ceremony will honor three remarkable individuals who have made significant impacts in their respective fields: Gloria Reuben, Dr. Jeanne Marrazzo, and Richard Lynn. Their dedication and commitment to health advocacy shine through their work and influence.
Spotlight on Gloria Reuben
Gloria Reuben is well-known not only as a talented singer and author but also as an actress and activist. Many recognize her for her compelling role as Jeanie Boulet on the acclaimed television series ER, where she portrayed a physician’s assistant navigating personal and professional challenges, including testing positive for HIV. Beyond television, she has made appearances in films and theatrical productions, and currently stars in the drama series Blue Bloods on CBS.
Dr. Jeanne Marrazzo's Leadership
Dr. Jeanne Marrazzo has been a prominent figure in public health, recently appointed as Director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health. Her journey reflects resilience, especially after facing unjust removal from her position due to alleged political reasons. With a commitment to advocating for effective health policies, she brings invaluable expertise to the forefront.
Richard Lynn: A Lifelong Advocate
Richard Lynn, affectionately known as Rich, is a longstanding board member of TAG and a passionate activist with a background in chemistry. His involvement began after completing graduate school, where he connected with ACT UP and later with TAG. Active since its inception in 1992, Rich has served on the board since 1998, continuing to uplift the voices of those impacted by these health issues. His partnership with fellow TAG supporter Joseph Evall strengthens their shared mission.
Special Performances and Art Exhibitions
The event will feature a captivating performance by Lorna Luft, daughter of the legendary Judy Garland. Luft's talents extend beyond singing, as she is also an author and producer, adding a touch of glamour to the awards night.
In conjunction with the awards, TAG will unveil a new Limited Art Edition, curated by board member Joy Episalla. The artwork, titled "George Platt Lynes Scrapbook Pages," is created by Matthew Leifheit, whose impressive resume includes work published in esteemed outlets. His art offers a unique lens on historical and cultural narratives, showcasing creativity in the fight against stigma.
Making an Impact through Community Support
Attending the Research in Action Awards is not just about celebrating achievements; it is also an opportunity to contribute to TAG's mission of providing life-saving treatment and education for individuals affected by HIV, TB, or HCV. Each ticket purchased and every donation made fosters ongoing initiatives to improve healthcare access and awareness.
We invite everyone to participate in this significant event, where community spirit prevails, and meaningful discussions take place about the ongoing battles faced by many. Your involvement helps ensure that vital resources reach those in need.
About TAG
Treatment Action Group (TAG) operates as an independent and activist-driven think tank, dedicated to enhancing treatment, prevention, and research efforts for HIV, tuberculosis, and hepatitis C. Through robust advocacy, TAG emphasizes the delivery of essential healthcare, focusing on equality for all affected populations. Their mission is a direct challenge to the status quo, aiming to expand research initiatives and facilitate healthy dialogues between research entities and the public.
Frequently Asked Questions
1. What is the Research in Action Awards event?
It's an annual celebration by TAG that honors individuals who have made outstanding contributions to health activism, specifically for those affected by HIV, TB, and HCV.
2. Who are the honorees for the 2025 awards?
The 2025 awards will honor Gloria Reuben, Dr. Jeanne Marrazzo, and Richard Lynn for their exceptional leadership and advocacy.
3. Where is the event taking place?
The awards ceremony will be held at the Angel Orensanz Foundation in New York City.
4. How can I support TAG's mission?
You can attend the Research in Action Awards, purchase tickets, and make donations to support TAG's initiatives.
5. What role does art play in the event?
The event features a Limited Art Edition curated by TAG members and showcases artwork that aligns with the mission of raising awareness and combating stigma.
About The Author
Contact Logan Wright privately here. Or send an email with ATTN: Logan Wright as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.